The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA
Open accessPublished version of a preprint
Abstract
MDMA, which has both therapeutic and abuse potential, engages a brain region–specific serotonergic pathway to produce its prosocial effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Furthermore, administration of methamphetamine, a potent DA releaser, did not enhance sociability [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“This simple form of 5-HT1b receptor-triggered synaptic plasticity was subsequently found to be generated by bath application of OXT or MDMA [41,51], results consistent with the 5-HT releasing properties of these agents.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In contrast, the actions of MDMA on the DA transporter (DAT) were not required for this prosocial effect, as prior administration of a DAT inhibitor did not influence MDMA's effects in the three-chamber assay.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Because of its abuse potential and potential toxicity [51,177], it is unlikely that MDMA itself can ever be used as a daily treatment for sociability deficits.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522 · cited 1×
“Social approach testing was performed similar to previously described methods (17).”
MethodThe Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin
Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013) · Nature · doi:10.1038/nature12518 · Cited by 1,161
Self-citationDrug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling
Lüscher, C., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.017 · Cited by 1,105
Self-citationCircuit architecture of VTA dopamine neurons revealed by systematic input-output mapping
Beier, K. T., Steinberg, E. E., DeLoach, K. E., Xie, S., Miyamichi, K., Schwarz, L., Gao, X. J., Kremer, E. J., Malenka, R. C., & Luo, L. (2015) · Cell · doi:10.1016/j.cell.2015.07.015 · Cited by 1,068
Self-citationGong, S., Doughty, M., Harbaugh, C. R., Cummins, A., Hatten, M. E., Heintz, N., & Gerfen, C. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2707-07.2007 · Cited by 977
Gating of social reward by oxytocin in the ventral tegmental area
Hung, L. W., Neuner, S., Polepalli, J. S., Beier, K. T., Wright, M., Walsh, J. J., Lewis, E. M., Luo, L., Deisseroth, K., Dölen, G., et al. (2017) · Science · doi:10.1126/science.aan4994 · Cited by 578
Self-citationRudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Griebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000) · Psychopharmacology · doi:10.1007/s002130050038 · Cited by 420
Flagged first, then by citations
Research works printed but not linked: 1
- S. Garattini R. Samanin Central Mechanisms of Anorectic Drugs (Monographs of the Mario Negri Institute for Pharmacological Research Raven Press 1978).
Cited by
Sorted by citations
Items 101–120 of 120
Cazadores de imágenes: Los ojos pioneros del documental Español
Sevilla, J. D. L. P. (2011) · Academia: Revista del Cine Español
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Bioisosteric analogs of MDMA with improved pharmacological profilePreprint
Alberto‐Silva, A. S., Hemmer, S., Bock, H. A., da Silva, L. A., Scott, K. R., Kastner, N., Bhatt, M., Niello, M., Jäntsch, K., Kudlacek, O., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.08.588083
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141
Nishitani, N., Sasaki, Y., & Kaneda, K. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12510
Genetic capture for conscious state transitionsPreprint
Heshmati, M., Lazaro, H., Schneider, K. N., Jin, M., Beck, A. I., Rijsketic, D. R., Murry, A. D., Navarrete, J. S., Shin, C. C., Barrow, A. C., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6192781/v1
Self-citationThe therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives
Rahmani, S., Crupi, R., Riley, A. L., & Davidson, T. L. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174087
Hyperactivity of the Amygdala Mediates Depressive-Like Phenotypes and Decreased Serotonin ReleasePreprint
He, J., Kim, K., Lai, Y., Gao, Q., Wang, H., Ying, K. T., & Asim, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7251588/v1
Ahari, N. J., & Fonzo, G. A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1665770 · Cited by 1
MDMA in Psychiatry: From PTSD to emerging indications, safety, and future directions
Zhao, M., Yang, J., & Hashimoto, K. (2025) · Psychedelics. · doi:10.61373/pp025i.0035
Serotonin modulates nucleus accumbens circuits to suppress aggressionPreprint
Zhang, Z., Touponse, G. C., Alderman, P. J., Yassine, T., Pomrenze, M. B., Harris, T. W., Shank, A. N., Malenka, R. C., & Eshel, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690732
Self-citationNext-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights
Kastner, N., Nadal‐Gratacós, N., Hemmer, S., da Silva, L. A., McKee, J. M. T., Hell, T., Cicalese, G., Holy, M., Kooti, F., Jäntsch, K., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00782
Cahill, E., Mediane, D. H., & Anastasiades, P. G. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5938356
MDMA enhances prefrontal plasticity and representational drift during fear extinctionPreprint
Geva, N., Jefferson, S. J., Krishnamurthy, E., Anderson, T. L., Rondeau, J. A., Wehrle, P. H., Rosado, A. F., Pittenger, C., Krystal, J. H., & Kaye, A. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.06.710094
Sáez‐Briones, P., Silva-Rodríguez, A., Morales-Vidal, M., Sepúlveda-Fernández, Y., Jara-Clen, D., Castro-Choapa, M., Livacic-Rojas, P. E., Martínez-Afani, D., Cassels, B. K., Barra, R., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1779772
Mediane, D. H., Anastasiades, P. G., & Cahill, E. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116300
Olejníková, L., Kútna, V., Mazochová, K., Šíchová, K., Danda, H., Lhotková, E., Uttl, L., Brejtr, V., Syrová, K., Mazoch, V., et al. (2026) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2026.174231
Averill, L. A., & Neitzke‐Spruill, L. (2026) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20260006
Targeting the serotonin 1B receptor for the treatment of depression and anxiety
Fleury, S., & Nautiyal, K. M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2738183
Metadata
- Authors
- Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R. C.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
- Albert Einstein College of Medicine (US)
- Corresponding author
- Malenka, Robert C.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2019-12-11
- Volume
- 11
- Issue
- 522
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7123941
- OpenAlex
- W2994786945
- Cited by
- 120
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 25 · 2023: 12 · 2022: 17 · 2021: 18 · 2020: 10
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH110610, MH115668, MG105839)
- National Institute on Drug Abuse (DA042012)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- MDMA, ecstasy, prosocial behavior, reward, addiction, abuse liability, serotonin release, fenfluramine, neural pathways, treatment development
- MeSH terms
- Animals, Brain, Dopamine, Female, Male, Mice, Inbred C57BL, Nucleus Accumbens, Receptors, Serotonin, Reward, Social Behavior, Receptors, Oxytocin, N-Methyl-3,4-methylenedioxyamphetamine, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
